***The Iowa Standard is an independent media voice. We rely on the financial support of our readers to exist. Please consider a one-time sign of support or becoming a monthly supporter at $5, $10/month - whatever you think we're worth! If you’ve ever used the phrase “Fake News” — now YOU can actually DO something about it! You can also support us on PayPal at [email protected] or Venmo at Iowa-Standard-2018 or through the mail at: PO Box 112 Sioux Center, IA 51250

On Thursday, Rep. Chip Roy (R-TX-21) reintroduced the “Reciprocity Ensures Streamlined Use of Lifesaving Treatments” (RESULT) Act to expedite the Food and Drug Administration’s approval process for potentially lifesaving medicines.

Rep. Roy said, “The American people should not have to wait years and years for bureaucrats at the FDA to sign off on medicines that are already approved in other trusted countries.

This bill would cut through another wall of red tape that separates Americans from care, which means taking power away from the pencil pushing gatekeepers and putting it back where it belongs — the doctor-patient relationship.”

Rep. Roy first introduced the RESULT Act in March 2020. This bill would amend the Food, Drug and Cosmetic Act to allow for reciprocal approval of drugs approved in other trusted nations. Additionally, the legislation would require the FDA to quickly review drug, device, and biologic applications from companies that have products approved and sold in developed and reliable countries.

Senators Ted Cruz (R-TX) and Mike Lee (R-UT) introduced companion legislation in the Senate.

Author: Press Release


Please enter your comment!
Please enter your name here